LBF20207PG72: Difference between revisions
(New page: {{Lipid/Header}} {{Hierarchy|{{PAGENAME}}}} {{Metabolite |LipidBank=XPR1793 |LipidMaps=LMFA03010122 |SysName=(9alpha,11alpha,15S) -Trihydroxy-15-methyl-prosta- (5-cis,13-trans) -dien-1-o...) |
No edit summary |
||
| Line 6: | Line 6: | ||
|LipidBank=XPR1793 | |LipidBank=XPR1793 | ||
|LipidMaps=LMFA03010122 | |LipidMaps=LMFA03010122 | ||
|SysName=(9alpha,11alpha,15S) -Trihydroxy-15-methyl-prosta- (5- | |SysName=(9alpha,11alpha,15S) -Trihydroxy-15-methyl-prosta- (cis-5,trans-13) -dien-1-oic acid, methyl ester | ||
|Common Name=&&15S-15-methyl Prostaglandin F_2 alpha methyl ester&&(9alpha,11alpha,15S) -Trihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid, methyl ester&& | |Common Name=&&15S-15-methyl Prostaglandin F_2 alpha methyl ester&&(9alpha,11alpha,15S) -Trihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid, methyl ester&& | ||
|Source= | |Source= | ||
Latest revision as of 08:47, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1793 |
| LipidMaps | LMFA03010122 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG72 |
| 15S-15-methyl Prostaglandin F2α methyl ester | |
|---|---|
| |
| Structural Information | |
| (9α,11α,15S) -Trihydroxy-15-methyl-prosta- (cis-5,trans-13) -dien-1-oic acid, methyl ester | |
| |
| Formula | C22H38O5 |
| Exact Mass | 382.271924326 |
| Average Mass | 382.53412000000003 |
| SMILES | C[C@@](O)(C=C[C@@H]([C@@H]1O)[C@H]([C@H](C1)O)CC=CCCCC(=O)OC)CCCCC |
| Physicochemical Information | |
| 15(S)-15methyl PGF2 alpha methylester is hydrolysed in vivo to 15(S)-15-methyl PGF2 alpha shown as a potent uterine stimulant and abortifacient. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
